FIGURE 3
FROM:
Stable Genetic Modification of Human Embryonic Stem Cells by Lentiviral Vectors
Michal Gropp, Pavel Itsykson, Orna Singer, Tamir Ben-Hur, Etti Reinhartz, Eithan Galun and Benjamin E. Reubinoff
BACK TO ARTICLEFigure 3.

Transgene expression throughout differentiation of transduced hES cells in vitro. (A) FACS analyses of transduced hES cells that were cultured for 1 and 4 weeks without passage. The percentages of EGFP-expressing cells are indicated together with the mean fluorescence intensity (in parentheses). (B, C) Phase-contrast (B) and fluorescence microscopy (C) images of cystic EBs, 20 days after generation from transduced hES cells. (D-H) Immunophenotyping of differentiated cells from disaggregated cystic EBs demonstrating co-expression of EGFP (green fluorescence) and indirect immunofluorescence staining (red) for the mesodermal markers muscle actin (D) and desmin (E), and the endodermal markers
-fetoprotein (F), laminin (G), and LMW cytokeratin (H). (I-J) Phase-contrast (I) and fluorescence microscopy (J) images of neural progenitor spheres generated from transduced hES cells. (K-R) Indirect immunofluorescence analyses of neural progenitors and their differentiated progeny demonstrating co-expression of EGFP (green) and markers (red) of the neural progenitors nestin (K), PSA-NCAM (L), and A2B5 (M); early neurons (
-tubulin III (N)); mature neurons (MAP 2a,b, (O) glutamate (P), NF-160 (Q)); and astrocytes (GFAP (R)). Arrows indicate cells co-expressing EGFP and markers. Scale bars represent 100
m (B, C, I, J), 20
m (D-H), and 10
m (K-R).
